Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia

Fig. 1

Study flowchart. BAL bronchoalveolar lavage, COP cryptogenic organizing pneumonia, CTD-ILD connective tissue disease-associated interstitial lung disease, DIP desquamative interstitial pneumonia, HP hypersensitivity pneumonia, IIP idiopathic interstitial pneumonia, iNSIP idiopathic non-specific interstitial pneumonia, IPF idiopathic pulmonary fibrosis, iPPFE idiopathic pleuroparenchymal fibroelastosis, MDD multidisciplinary discussion, RB-ILD respiratory bronchiolitis-associated interstitial lung disease. Of the 465 cases analyzed in the previous study [17], 200 cases diagnosed with IPF, 5 cases diagnosed with COP, and 9 cases diagnosed with DIP/RB-ILD by MDD were excluded. Twenty-one cases diagnosed with ILD other than IIPs [HP (n = 12), CTD-ILD (n = 5), lymphoproliferative disease (n = 3), and invasive mucinous adenocarcinoma (n = 1)] were also excluded. Of the 230 patients with fibrotic IIPs other than IPF, 44 cases for whom BAL was not performed were excluded. Finally, 186 patients were included for analysis

Back to article page